Trials / Unknown
UnknownNCT03561116
Effects of Xanthohumol on Metabolic Syndrome Progression
Effects of Xanthohumol on Metabolic Syndrome Progression (XAN4Health)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- Sponsor
- Universidade do Porto · Academic / Other
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A huge body of scientific evidence has suggested that xanthohumol (XAN) consumption, a polyphenol present in beer, has a positive effect on energy metabolism. This compound is known for its antioxidant, anti-inflammatory and anti-cancer properties which confer potential to be used as a food supplement. Nevertheless, XAN lipophilic properties prevent the extensive use of this molecule as a functional food compound. The company TA-XAN S.A.M. (Wiesbaden, Germany) has patented a method to overcome this solubility problem. So, the main aim of this study is to evaluate the effects of XAN consumption on metabolic syndrome progression in individuals recently diagnosed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | XAN | Daily intake of a sachet containing 12 mg of XAN |
| DIETARY_SUPPLEMENT | Placebo | Daily intake of a sachet containing excipient |
Timeline
- Start date
- 2018-05-19
- Primary completion
- 2018-09-01
- Completion
- 2018-10-01
- First posted
- 2018-06-19
- Last updated
- 2018-06-19
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT03561116. Inclusion in this directory is not an endorsement.